Malignant mixed Mullerian tumor

Search Trials
Paclitaxel/Carboplatin + Galunisertib for Patients With Carcinosarcoma of the Uterus or Ovary
Status:
Recruiting
Last Changed:
Sep 26, 2017
First Changed:
Jul 2, 2017
Disease(s):
Carcinosarcoma, Ovarian
Intervention(s):
GalunisertibPaclitaxelCarboplatin
Dual mTorc Inhibition in advanCed/Recurrent Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer (of Clear Cell, Endometrioid and High Grade Serous Type, and Carcinosarcoma)
Status:
Recruiting
Last Changed:
Feb 27, 2019
First Changed:
Aug 27, 2018
Disease(s):
Ovarian Cancer
Intervention(s):
PaclitaxelTAK228
Recurrent Ovarian CarcinoSarcoma Anti-pd-1 Niraparib
Status:
Not yet recruiting
Last Changed:
Aug 29, 2018
First Changed:
Aug 29, 2018
Disease(s):
Ovarian Carcinosarcoma
Intervention(s):
NiraparibNiraparib plus TSR-042Chemotherapy Drugs
Trial On Trabectedin In The Treatment Of Advanced Uterine And Ovarian Carcinosarcoma (CS)_MITO 26
Status:
Not yet recruiting
Last Changed:
Dec 15, 2016
First Changed:
Dec 15, 2016
Disease(s):
Carcinosarcoma, Ovarian
Intervention(s):
Trabectedin

Connect. Empower. Inspire.